Paul-Henri Cottu

26PUBLICATIONS
139CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markersSocial epidemiologyExercise physiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (26)

|Aug 15, 2026
Rationale and trial design of RIBOLARIS: A phase II trial of neoadjuvant and adjuvant ribociclib plus endocrine therapy for clinically high-risk HR+/HER2-negative breast cancer.

|Feb 18, 2026
Reducing waiting time of injectable anticancer drug preparations in day care oncology units: A summary of evidence, implemented strategies, and perspectives for hospital pharmacists.

Jean-Stéphane Giraud, Mélanie Brun, Romain Desmaris

|Nov 12, 2025
An Extracellular Matrix-Producing Subset of Cancer-Associated Fibroblasts Drives Chemoresistance in Breast Cancer via SRC Activation and G0S2 Upregulation.

Isabella Hofer, Yann Kieffer, Arianna Mencattini

|Apr 14, 2025
Development of a Prognostic Score in Patients With Advanced Breast Cancer Treated for Meningeal Carcinomatosis.

Grégoire Narjoux, Juliette Mainguené, Marie-Noëlle Guilhaume

|Aug 28, 2024
Facilitating patient-oncologist communication in advanced treatment-resistant cancer: development and feasibility testing of a question prompt list.

A Rault, S Dolbeault, J Terrasson

|Aug 06, 2024
Metabolomic Prediction of Breast Cancer Treatment-Induced Neurologic and Metabolic Toxicities.

Max Piffoux, Jérémie Jacquemin, Mélanie Pétéra

Pageof 5

Frequent Collaborators

7 joint publications

Ines Vaz-Luis

7 joint publications

Fabrice Andre

7 joint publications

Anne-Laure Martin

6 joint publications

Antonio Di Meglio